{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:47:29Z","timestamp":1793159249340,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12325-021-01743-5","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T11:02:49Z","timestamp":1623409369000},"page":"4026-4039","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cost-Effectiveness of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome from Vietnamese Healthcare Payers\u2019 Perspective"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3394-8570","authenticated-orcid":false,"given":"Thuy","family":"Thi Thu Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung","family":"Van Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Mellstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan","family":"Quang Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung","family":"Manh Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sy","family":"Van Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thinh","family":"Cong Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tri","family":"Le Phuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"1743_CR1","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"CW Hamm","year":"2011","unstructured":"Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2999\u20133054.","journal-title":"Eur Heart J"},{"issue":"42","key":"1743_CR2","first-page":"33","volume":"2014","author":"F Vengoechea","year":"1995","unstructured":"Vengoechea F. Management of acute coronary syndrome in the hospital: a focus on ACCF\/AHA guideline updates to oral antiplatelet therapy. Hosp Pract. 1995;2014(42):33\u201347.","journal-title":"Hosp Pract"},{"key":"1743_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jacc.2012.06.004","volume":"60","author":"H Jneid","year":"2012","unstructured":"Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casay DE, et al. 2012 ACCF\/AHA focused update of the guideline for the management of patients with unstable angina\/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2012;60:645\u201381.","journal-title":"J Am Coll Cardiol"},{"key":"1743_CR4","first-page":"e362","volume":"127","author":"PT O'Gara","year":"2013","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, Lemos JA, et al. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362-425.","journal-title":"Circulation"},{"key":"1743_CR5","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"PG Steg","year":"2012","unstructured":"Task Force on the management of STseamiotESoC, Steg PG, James SK, Atar D, Badano LP, Bl\u00f6mstrom-Lundqvist C, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569\u2013619.","journal-title":"Eur Heart J"},{"key":"1743_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","volume":"27","author":"S Husted","year":"2006","unstructured":"Husted S, Emanuelsson H, Heptinstall S, Sandset PM, Wickens M, Peters G, et al. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin. Eur Heart J. 2006;27:1038\u201347.","journal-title":"Eur Heart J"},{"key":"1743_CR7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045\u201357.","journal-title":"N Engl J Med"},{"key":"1743_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/CIR.0b013e318256f1e0","volume":"126","author":"M Writing Committee","year":"2012","unstructured":"Writing Committee M, Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, et al. 2012 ACCF\/AHA focused update of the guideline for the management of patients with unstable angina\/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2012;126:875\u2013910.","journal-title":"Circulation"},{"key":"1743_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/eurheartj\/ehs149","volume":"34","author":"E Nikolic","year":"2013","unstructured":"Nikolic E, Janzon M, Hauch O, Wallentin L, Henriksson M. Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study. Eur Heart J. 2013;34:220\u20138.","journal-title":"Eur Heart J"},{"key":"1743_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.11622\/smedj.2013045","volume":"54","author":"CT Chin","year":"2013","unstructured":"Chin CT, Mellstrom C, Chua TSJ, Matchar DB. Lifetime cost-effectiveness analysis of ticagrelor in patients with acute coronary syndromes based on the PLATO trial: a Singapore healthcare perspective. Singap Med J. 2013;54:169\u201375.","journal-title":"Singap Med J"},{"key":"1743_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jacc.2014.11.034","volume":"65","author":"PA Cowper","year":"2015","unstructured":"Cowper PA, Pan W, Anstrom KJ, Kaul P, Wallentin L, Davidson-Rayet L, et al. Economic analysis of ticagrelor therapy from a US perspective. J Am Coll Cardiol. 2015;65:465\u201376.","journal-title":"J Am Coll Cardiol"},{"key":"1743_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s40267-013-0088-y","volume":"29","author":"KA Lyseng-Williamson","year":"2013","unstructured":"Lyseng-Williamson KA. Ticagrelor: a review of its cost effectiveness in the management of acute coronary syndromes. Drugs Ther Perspect. 2013;29:379\u201386.","journal-title":"Drugs Ther Perspect"},{"issue":"1","key":"1743_CR13","first-page":"313","volume":"21","author":"TTT Nguy\u1ec5n","year":"2017","unstructured":"Nguy\u1ec5n TTT, Th\u00e2n TTV, Nguy\u1ec5n TTT, Phan TTN. Ph\u00e2n t\u00edch chi ph\u00ed - hi\u1ec7u qu\u1ea3 c\u1ee7a ticagrelor so v\u1edbi clopidogrel trong \u0111i\u1ec1u tr\u1ecb h\u1ed9i ch\u1ee9ng m\u1ea1ch v\u00e0nh c\u1ea5p: nghi\u00ean c\u1ee9u theo quan \u0111i\u1ec3m c\u01a1 quan b\u1ea3o hi\u1ec3m y t\u1ebf Vi\u1ec7t Nam. T\u1ea1p ch\u00ed Y h\u1ecdc Th\u00e0nh ph\u1ed1 H\u1ed3 Ch\u00ed Minh. 2017;21(1):313\u201320.","journal-title":"T\u1ea1p ch\u00ed Y h\u1ecdc Th\u00e0nh ph\u1ed1 H\u1ed3 Ch\u00ed Minh"},{"key":"1743_CR14","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1136\/hrt.2007.135038","volume":"94","author":"A Norhammar","year":"2008","unstructured":"Norhammar A, Stenestrand U, Lindback J, Wallentin L. Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Heart. 2008;94:1565\u201370.","journal-title":"Heart"},{"key":"1743_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1161\/01.STR.24.6.796","volume":"24","author":"MS Dennis","year":"1993","unstructured":"Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP, et al. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1993;24:796\u2013800.","journal-title":"Stroke"},{"issue":"342","key":"1743_CR16","doi-asserted-by":"publisher","first-page":"d3527","DOI":"10.1136\/bmj.d3527","volume":"2011","author":"SK James","year":"2011","unstructured":"James SK, Roe MT, Cannon CP, Cornel JH, Horrow J, Husted S, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial. BMJ. 2011;2011(342):d3527.","journal-title":"BMJ"},{"key":"1743_CR17","unstructured":"Edejer TT. World Health Organization. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization, 2003."},{"key":"1743_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/0167-6296(93)90005-Y","volume":"12","author":"M Johannesson","year":"1993","unstructured":"Johannesson M, Weinstein MC. On the decision rules of cost-effectiveness analysis. J Health Econ. 1993;12:459\u201367.","journal-title":"J Health Econ"},{"key":"1743_CR19","unstructured":"WHO Commission on Macroeconomics and Health. Macroeconomics and health: investing in health for economic development. Report of the Commission on Macroeconomics and Health. Geneva: World Health Organization, 2001."},{"key":"1743_CR20","unstructured":"The World Bank. GDP per capita (current US$) \u2013 Vietnam, https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=VN. Accessed 30 Nov 2018."},{"issue":"899\u2013905","key":"1743_CR21","first-page":"e1","volume":"169","author":"HJ Kang","year":"2015","unstructured":"Kang HJ, Clare RM, Gao R, Held C, Himmelmann A, James SK, et al. Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: a retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Am Heart J. 2015;169(899\u2013905):e1.","journal-title":"Am Heart J"},{"key":"1743_CR22","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1093\/eurheartj\/ehq325","volume":"31","author":"S James","year":"2010","unstructured":"James S, Angiolillo DJ, Cornel JH, Erlinge D, Husted S, Kontny F, et al. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J. 2010;31:3006\u201316.","journal-title":"Eur Heart J"},{"key":"1743_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/CEOR.S51052","volume":"6","author":"DT Grima","year":"2014","unstructured":"Grima DT, Brown ST, Kamboj L, Bainey KA, Goeree R, Oh P, et al. Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada. Clinicoecon Outcomes Res. 2014;6:49\u201362.","journal-title":"Clinicoecon Outcomes Res"},{"key":"1743_CR24","first-page":"w13851","volume":"143","author":"D Gasche","year":"2013","unstructured":"Gasche D, Ulle T, Meier B, Greiner RA. Cost-effectiveness of ticagrelor and generic clopidogrel in patients with acute coronary syndrome in Switzerland. Swiss Med Wkly. 2013;143:w13851.","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"1743_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13561-014-0017-3","volume":"4","author":"S Yamwong","year":"2014","unstructured":"Yamwong S, Permsuwan U, Tinmanee S, Sritara P. Long-term cost effectiveness of ticagrelor in patients with acute coronary syndromes in Thailand. Heal Econ Rev. 2014;4(1):17.","journal-title":"Heal Econ Rev"},{"key":"1743_CR26","first-page":"531","volume":"35","author":"A Mejia","year":"2015","unstructured":"Mejia A, Senior JM, Ceballos M, Atehort\u00faa S, Toro JM, Saldarriaga C, et al. Cost-effectiveness analysis of ticagrelor compared to clopidogrel for the treatment of patients with acute coronary syndrome in Colombia. Biomedica. 2015;35:531\u201340.","journal-title":"Biomedica"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01743-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01743-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01743-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T04:23:51Z","timestamp":1626236631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01743-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1743"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01743-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}